Australia Genomics

What Australia Genomics does

Australian Genomics was a national collaboration established in 2015 to support the translation of genomic research into clinical practice across Australia. Operating through a distributed network of more than 100 partner organisations — including hospitals, universities, research institutes, sequencing laboratories, and community organisations across all Australian states and territories — the organisation coordinated 24 priority projects spanning the full value chain from genomic implementation and clinical practice through to workforce training, Indigenous genomic priorities, data governance, and health system policy. Its portfolio of tools and resources included the CTRL dynamic consent platform for managing participant consent, the NAGIM Blueprint framework delivered to the Federal Government for national genomic information management, a Data Commons and Analysis Platform for cloud-based storage and sharing of nationally significant genomic data, and standardised clinical consent materials (consent forms, patient fact sheets, health professional guides) released in January 2024 and adopted by Australian genetics services.

The organisation was funded through government grants and research funding rather than commercial revenue. All tools, resources, publications, and datasets were provided for public use, and the go-to-market model was community-led coordination rather than product sales. Distribution was entirely through the organisational website with engagement via DNA dialogue seminars and content marketing. Customer and partner relationships were structured as mutual strategic co-development across the health, academic, and community sectors, with dedicated partnerships including the Genomics Education Network of Australasia, Melbourne Genomics Health Alliance, and state pathology services for Clinical NAGIM pilots.

Following a decade of collaboration, Australian Genomics concluded operations in 2025, with its work transitioned to Genomics Australia — a new national body established on 1 July 2025 within the Commonwealth Department of Health, Disability and Ageing to provide ongoing leadership, coordination, and expertise in health genomics.

Name

Australia Genomics

Legal name

Australian Genomics

Website

https://australiangenomics.org.au

Company type

Private

Founded year

2015

Operating status

Closed

Headcount range

51–100 employees

Short description

Australian Genomics was a national collaboration, founded in 2015, that coordinated genomic research translation into clinical practice across Australia through a network of 100+ partner hospitals, universities, and research institutes, funded by government grants and concluded in 2025.

Ownership category

akta.pro rank

Product category

Genomic Research Coordination Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genomic Profiling & Sequencing-Based Precision Medicine (HLAAANAA)

akta.pro secondary industry

Population Genomics & Preventive Precision Health Programs (HLAAANAL)

Keywords

• Genomic research coordination
• Clinical genomics translation
• Genomic data management
• Consent management platform
• Genomic medicine education

Headquarters

HQ city

Parkville

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Research Funding and Grants: Australia Genomics operates as a national research collaboration funded through government grants and research funding. The organisation coordinates genomic research and translation activities rather than generating commercial revenue from products or services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Australian Genomics coordinated, conducted and enabled genomic research through a national network of more than 100 partners across Australia, delivering tools, resources, frameworks and platforms that translate genomic research into clinical practice. Core deliverables include the CTRL dynamic consent platform, the NAGIM Blueprint for national genomic information management, a Data Commons and Analysis Platform for genomic data sharing, standardised consent materials for clinical genomic testing, and workforce education programs.

Product overview

Australia Genomics is a national research collaboration that coordinates and enables genomic research through a network of partners. Rather than a single software product, it offers a portfolio of tools, resources, and frameworks including the CTRL dynamic consent platform for managing participant consent, standardized consent forms and patient/health professional resources, and the NAGIM Blueprint framework for national genomic information management. The organization supports 24 priority projects across areas including genomic implementation, clinical practice, workforce training, Indigenous genomic priorities, and data governance. The Data Commons and Analysis Platform enables cloud-based storage and sharing of genomic research data.

Differentiator

Problem solved

Functional benefit

Products and services

• CTRL Platform A dynamic consent platform developed by Australian Genomics that streamlines how research teams manage patient and participant consent for genomic testing and data sharing across research projects.
• Clinical and Research Consent Materials for Genomic Testing A standardised package of clinical consent forms, genetic testing consent forms, patient fact sheets and a health professional guide for genomic testing, adapted by Australian genetics services for consistent patient consent processes.
• NAGIM Blueprint (Blueprint for a National Approach to Genomic Information Management) A digital genomics blueprint developed for the Federal Government providing best practice principles to guide an Australian strategy for managing genomic information across research and clinical sectors.
• Data Commons and Analysis Platform A cloud-based and hybrid platform for storing, analysing and sharing genomic data from nationally significant genomic projects on a national scale, piloted with state pathology partners and clinical genetics services.

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and major.

• Australian HospitalscoreStrategic or Co-development PartnerPart of the national network of 100+ partners coordinating genomic research and clinical translation across Australia's healthcare system
• Australian UniversitiescoreStrategic or Co-development PartnerAcademic partners contributing to genomic research, workforce education, and translation activities within the national collaboration
• Research Institutes and CentrescoreStrategic or Co-development PartnerResearch institution partners supporting genomic research projects, data infrastructure development, and clinical translation initiatives
• Sequencing LaboratoriescoreStrategic or Co-development PartnerLaboratory partners involved in pilot projects for genomic information management and clinical data sharing across jurisdictions
• Community OrganisationscoreStrategic or Co-development PartnerCommunity partners including Indigenous organisations contributing to culturally appropriate genomic resources and research priorities
• Genomics Education Network of Australasia (GENA)coreStrategic or Co-development PartnerNetwork of education providers, evaluators and researchers working to promote best practice in genomic education through shared experiences, resources, evaluation tools and research outcomes
• Victorian Clinical Genetics ServicemajorTechnology or IntegrationPilot Laboratory Working Group member for Clinical NAGIM project focusing on national approach to managing clinical genomic and healthcare data
• Pathology QueenslandmajorTechnology or IntegrationPilot Laboratory Working Group member for Clinical NAGIM project contributing to feasibility pilot for establishing national network of clinical genomic databases
• NSW Health PathologymajorTechnology or IntegrationPilot Laboratory Working Group member for Clinical NAGIM project participating in data sharing pilot across jurisdictions
• SA PathologymajorTechnology or IntegrationState health pathology service partner leading state health systems consistency project and contributing to clinical laboratory delivery initiatives
• Melbourne Genomics Health AlliancemajorStrategic or Co-development PartnerRegional genomics alliance collaborating on workforce education initiatives and genomics literacy programs

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Global Alliance for Genomics and Health (GA4GH): GA4GH is an international policy-framing alliance developing standards and frameworks for responsible genomic data sharing across institutions and countries. It is thematically comparable to Australian Genomics' NAGIM Blueprint and data governance work, operating as an enabling ecosystem participant rather than a direct competitor.

Direct peers

• NIH All of Us Research Program: The All of Us Research Program is a US National Institutes of Health initiative building a national research cohort of one million participants to advance precision medicine. It is directly comparable to Australian Genomics as a federally funded, national-scale population genomics programme focused on data infrastructure and translational research.
• Melbourne Genomics Health Alliance: Melbourne Genomics Health Alliance is a Victorian consortium of hospitals, research and academic institutions translating genomics into clinical care. It is a direct Australian peer and active collaborator with Australian Genomics, with overlapping focus areas including clinical genomic practice, workforce education, and data sharing infrastructure.
• Genome Canada: Genome Canada is a Canadian federally funded not-for-profit organisation that supports large-scale genomics research and translation across the country. It is directly comparable to Australian Genomics as a national research-coordination body funding priority projects across a network of regional Genome Centres and partner institutions.
• FinnGen: FinnGen is a public-private partnership research project combining genome data of Finnish biobank participants to identify disease-associated genetic variants. It is comparable to Australian Genomics as a national-scale genomics research consortium generating population-level genomic insights with strong public-sector coordination.
• Genomics England: Genomics England is a UK government-owned company that coordinates the 100,000 Genomes Project and now runs the NHS Genomic Medicine Service, serving as the most directly comparable national genomic research-to-clinical-translation initiative supported by public funding. It maps closely to Australian Genomics in mission, structure, and national-scale coordination of clinical genomics.

Regional players

• Estonian Biobank (Estonian Genome Centre): The Estonian Biobank is a population-based biobank at the University of Tartu covering ~20% of Estonia's adult population, providing a national-scale genomic and health data resource. It is comparable to Australian Genomics' data infrastructure and population genomics ambitions, though at a smaller country scale.
• Genomics Aotearoa: Genomics Aotearoa is a New Zealand national genomics research platform funded by the Ministry of Business, Innovation and Employment. It is closely comparable to Australian Genomics in mission, structure, and funding model, with a similar focus on translating genomics into health, environmental, and primary sector outcomes across a small developed country.
• Australian BioCommons: Australian BioCommons is a national bioinformatics infrastructure platform providing compute, data, and tooling capacity to Australian life science researchers. It is a comparable Australian infrastructure/coordination body whose tooling and data commons work overlaps with Australian Genomics' Data Commons and Analysis Platform.

Emerging players

• Genomics4RD: Genomics4RD is a Canadian initiative coordinating rare disease genomic sequencing across multiple provinces with cross-jurisdictional data sharing. It is comparable to Australian Genomics' rare disease coordination work (e.g., the Rare Disease Collective) and Clinical NAGIM cross-jurisdictional data sharing pilots.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/AGHA_tweets
• Facebookfacebook.com/AustralianGenomics
• LinkedInlinkedin.com/company/australian-genomics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australia Genomics